XML 109 R91.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Payment (Narrative) (Details)
1 Months Ended 12 Months Ended
Aug. 31, 2000
Dec. 31, 1998
Dec. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
Dec. 31, 2020
$ / shares
Dec. 31, 2019
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Stock option reserve for grant     4,000 37,000 4,249  
Options outstanding     49,394 48,684 31,135 34,886
Weighted average remaining contractual life outstanding     8 years 4 months 24 days 9 years 4 months 17 days 7 years 7 months 13 days  
Exericse prices for share options outstanding     $ 26.98 $ 26.16 $ 12.94 $ 9.83
Bottom of range [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Exericse prices for share options outstanding     8.41 8.41 5.55  
Top of range [member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Exericse prices for share options outstanding     $ 34.44 $ 34.44 $ 34.44  
Plan 1998 Member            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Stock option expiration term   10 years        
Stock option extended expiration term   December 8, 2028        
Stock option reserve for grant   75,000        
Stock option expiration date   December 8, 2008        
Options outstanding     14,749      
Ordinary shares available for future grants     22,667      
Plan 1998 Member | Director [Member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Stock option reserve for grant     4,000 4,000 4,249  
Plan 2000 Member            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Stock option expiration term 10 years          
Stock option reserve for grant 200,000          
Stock option expiration date August 31, 2028          
Stock option vesting term over a three year period          
Percentage of exercise price 80.00%          
Options outstanding     34,645      
Ordinary shares available for future grants     547,206